Single-dose dye imaging for lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are strongly suspected to have lung cancer (non-small cell type).
- You are planning to have surgery to remove a lung tumor through a small camera (thoracoscopy).
- You are willing to use birth control (if you could become pregnant) or are not able to have children.
- You are not allergic to indocyanine green (a dye used in some imaging tests).
- You do not have serious kidney, liver, or heart problems that might make the surgery risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new PET scan dye (called 18F-Alfatide) that might help doctors see lung cancer and its spread more clearly before surgery. If it works, it could make sure surgery removes all the cancer.
This trial tests a dye that makes lung cancer cells glow during surgery, helping surgeons remove more of the tumor. It's for people who are already scheduled for lung cancer surgery.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This trial tests a special imaging drug (IRDye800CW-nimotuzumab) that may help surgeons better see lung cancer tissue during planned lung surgery. Phase 1/2 looks mainly at safety and how well the imaging works to guide the operation.
This study tests a dye called ICG that makes cancer cells glow under a special camera. Doctors use it during surgery to find and remove lung tumors that have spread from another cancer.
Hear when a new Non Small Cell Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.